# NeuroXess

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuroxess

- Industry: Medical Devices & Equipment
- Headquarters: Nanchang, China
- Website: www.tiger-braintech.com
- Latest round: Series A (Dec 28, 2022)
- Investors on record: 8

## About

Based in Nanchang, China, and established in 2021, NeuroXess is a medical equipment company that focuses on R&D of invasive brain-computer interface. The company was established by Mr. Hu Tao, and Mr.Lei Peng. Mr Hu Tao served as a researcher of Shanghai Institute of Microsystems, Chinese Academy of Sciences, who has experience in the field of brain-computer interface, artificial intelligence, micro-nano sensor. Mr. Lei Peng is a serial entrepreneur, who founded a Saas company, Keruyun, acquired by Alibaba Group for RMB 1 billion. 

The company's products can be divided into clinical products, and scientific research products, based on the technologies of design chip, flexible electrode processing, high-throughput algorithms, surgical robotics. The clinical products include NH electrodes and related accessories. The scientific research products includes NPc intracranial cortical electrodes, NRi intracranial deep electrodes, and related accessories. Those electrodes thickness is 1.5um, and implantation method is no craniotomy, semi-automatic minimally invasive implantation. The company has established cooperation with many hospitals that two hospitals passed ethical approval.

## Funding rounds

- Series A, Dec 28, 2022 — Hong Shan, Shanda Capital, New Alliance Capital, Sailing Capital, Light Silver Capital, Fujian Yanhua Boyi Technology, Zhongping Capital, Chengdu Bio-town

## Investors

- Hong Shan — Series A
- Shanda Capital — Series A
- New Alliance Capital (https://capitalatlas.ai/funds/new-alliance-capital) — Series A
- Sailing Capital (https://capitalatlas.ai/funds/sailing-capital) — Series A
- Light Silver Capital (https://capitalatlas.ai/funds/light-silver-capital) — Series A
- Fujian Yanhua Boyi Technology — Series A
- Zhongping Capital (https://capitalatlas.ai/funds/zhongping-capital) — Series A
- Chengdu Bio-town — Series A